Stem Cells
An Alternative Therapy for COVID-19 and Cytokine Storm
- 1st Edition - November 28, 2023
- Imprint: Academic Press
- Editors: Yogesh Kumar Verma, Neeraj Kumar Satija, Pawan Kumar Raghav, Nishant Tyagi, Subodh Kumar
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 9 5 5 4 5 - 4
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 5 5 4 6 - 1
Stem Cells: An Alternative Therapy for COVID-19 and Cytokine Storm provides mechanistic insights into the role of stem cells to combat COVID-19 outbreak and other pathol… Read more
Purchase options
Stem Cells: An Alternative Therapy for COVID-19 and Cytokine Storm provides mechanistic insights into the role of stem cells to combat COVID-19 outbreak and other pathologies where cytokines storm is the cause of concern for e.g., radiation exposure, multiple organ failure and sepsis. There has been an increase in number of cases of new diseases in the last decade, including mucormycosis, Zika virus, H1N1 influenza virus, among others. These diseases can be characterized by the induction of cytokine storm, which is mainly responsible for morbidity and mortality.
Stem cell therapy has emerged as a potential treatment for viral diseases, including, but not limited to, COVID-19. Interestingly, clinical trials in patients with COVID-19 complications depicted faster recovery in patients post mesenchymal stem cells therapy owing to the decreased cytokines levels, anti-viral effects and regeneration of the infected tissue.
Stem cell therapy has emerged as a potential treatment for viral diseases, including, but not limited to, COVID-19. Interestingly, clinical trials in patients with COVID-19 complications depicted faster recovery in patients post mesenchymal stem cells therapy owing to the decreased cytokines levels, anti-viral effects and regeneration of the infected tissue.
- Evaluates the role of MSCs to combat cytokine storm, the challenges regarding COVID-19 therapy and how they can be countered using stem cells, and the risk of opportunistic infections post COVID-19
- Presents how stem cell therapy has emerged as a potential treatment for viral diseases, including, but not limited to, COVID-19
- Provides a detailed understanding of the novel coronavirus, with an emphasis on therapeutic aspects
Researchers, practitioners, and industry partners in Regenerative Medicine and/or Stem Cells, Students and Instructors in Regenerative Medicine/Stem Cell courses
Part 1: Outbreak of Novel Disease
- 1. Targets of SARS-CoV-2: Therapeutic Implications for COVID-19
- Rajni Chadha, Aditya Raghav, Basudha Banerjee, Anugya Sengar, Manisha Sengar, Pawan Kumar Raghav
- 2. COVID-19 Biology: Cytokine Storms and Their Implications
- Nazente Atceken, Gul Kozalak
- 3. Comparative Clinical Investigation of Blood Profiling in COVID-19 Patients
- Shewta Kulshrestha, Aditya Raghav, Rajini Chadha, Pawan Kumar Raghav
- 4. SARS-CoV-2 Associated Complications
- Sumit Kumar, Vikram Khanna
- 5. COVID-19 Diagnostic Approaches and Modern Mesenchymal Stem Cell-Based Treatment
- Rajesh Kumar, Shewta Kulshreshta, Anjali Lathwal, Pawan Kumar Raghav
- 6. Modulation of Pentose Phosphate Pathway Augments the Efficacy of 2-deoxy-D-glucose in COVID-19 Management
- Simran Chopra, Ashrit Nair, Navneet Sharma, Viney Jain, Rakesh Kumar Sharma
- 7. Therapeutic Landscape of SARS-CoV-2
- Vivek Pandey, Shivani Sharma, Vikrant Singh, Birendra Kumar Yadav, Yuba Raj Pokharel
- 8. Pharmacotherapeutics for Cytokine Storm in COVID-19
- Rishi Pal, Manju Jyoti Chaudhary
- 9. Clinical Investigation of COVID-19 Prevention and Treatment
- Shweta Kulshrestha, Aditya Raghav, Rajni Chadha, Pawan Kumar Raghav
- 10. Potential Therapeutic Landscape of COVID-19: Molecular Targets, Repurposed Drugs, and Nano- and Cell-Based Intervention
- Sarika Tomar, Priyanka Surya, Rakesh Pandey, Raunak Varshney, Sweta Singh
- 11. Medical Care for SARS-CoV-2
- Ratnesh Singh Kanwar, Reena Wilfred, Shivi Uppal, Shadha Abduljaleel Al-Rawi, Zulfaquar Ahmad Arfi, Yogesh Kumar Verma, Harendra Mahto
- 12. Therapeutic Approaches for Opportunistic Infections Post-COVID-19 Pandemic
- Subodh Kumar, Piyush Garg, Sarika Tomar, Sweta Singh, Harender Mahto, Yogesh Kumar Verma
- 13. Focusing on the Cytokine Storm in the Battle Against COVID-19: The Rising Role of Mesenchymal-derived Stem Cells
- Abdul Naeem, Arshi Waseem, Abu Junaid Siddiqui, Beauty Ray, Riya Sinha, Abdul Quiayoom Khan, Rizwanul Haque, Syed Shabad Raza
- 14. Cytokine Storm in COVID-19 and Other Diseases: Emerging Therapeutic Interventions
- Shivani Sahu, Renu Dharra, Manisha Gun, Sonal Datta, Ajit Kumar Akela, Ashwani Kumar
- 15. Stem Cells as Therapeutics and Their Implications in Cytokine Storm in COVID-19
- Priyanka Surya, Sarika Tomar, Rakesh Pandey, Soumyata Pathak, Parul Sharma, Mansi Kumari, Sweta Singh
- 16. Visualizing Chemical Functionality and Structural Insights Into SARS-CoV-2 Proteins
- Meetali Sinha, Shraddha Pandit, Prakrity Singh, Shweta Singh Chauhan, Ramakrishnan Parthasarathi
- 17. Mesenchymal Stromal Cells and Pleiotropic Therapeutic Advantages in COVID-19 Management
- Vimal Kishor Singh, Uttkarsh Kumar Sharma Vaksh, Pallavi Sharma
- 18. Mesenchymal Stem Cells - Role in Tuberculosis Pathogenesis and Persistence
- Sapna Bajeli, Shweta Singh, Rahendra Singh Rajpurohit, Rinku Thakran, Sonal Datta, Ashwani Kumar
- 19. Radiosensitivity of Cancer Stem Cells Holds Promise for the Outcome in Radiotherapy and COVID-19 Infection
- Kaushala Prasad Mishra
- 20. Immunomodulatory Therapeutic Potential of Mesenchymal Stem Cells in COVID-19 Pathogenesis
- Kulwant Singh, Alok Kumar
- 21. Clinical Limitations of Stem Cells Therapy
- Pooja Yadav, Ravina Vats, Afsareen Bano, Rashmi Bhardwaj
- 22. Clinical Limitations in Stem Cell Therapy
- Pranav K Pandey
- 23. Stem Cell Based Products and the Regulatory Hurdle Race
- Poonam Malhotra, Sumit Kumar Saraswat, Nitin Khatri, Ranjan Verma, Rajan Datt, Siddharth Pandey
- 24. Implications of Stem Cell Therapy on the Socio-Scientific Community
- Suja Ann Mathew
- Edition: 1
- Published: November 28, 2023
- Imprint: Academic Press
- Language: English
YV
Yogesh Kumar Verma
Dr. Yogesh Kumar Verma, MNABS, is working as Scientist ‘E’ in INMAS, DRDO, Delhi, India. He completed his M.Sc. and Ph.D. in Biomedical Science from Delhi University, India. He also has another M.Sc. degree in Bioinformatics from Punjab Technical University, India. In year 2009, he joined INMAS, DRDO, Delhi, India, as Scientist ‘C’. He is presently working in the area of stem cell research, microencapsulation, regenerative medicine, tissue engineering and omics data mining and analysis for repairing/ regenerating various types of tissues for Defence application. He has been awarded with many fellowships, project grants, and has published many articles including manuscripts, patents, book chapters etc.
Affiliations and expertise
Scientist ‘E’, Stem Cell and Gene Therapy Research Group, Institute of Nuclear Medicine and Allied Sciences, Delhi, IndiaNS
Neeraj Kumar Satija
Dr. Neeraj Kumar Satija PhD is working as a Senior Scientist at CSIR-Indian Institute of Toxicology Research, Lucknow, India. He completed his B.Tech and M.Tech in Biotechnology from School of Biotechnology, Guru Gobind Singh Indraprastha University, Delhi, India. Thereafter, he undertook doctoral studies at Institute of Nuclear Medicine and Allied Sciences, Delhi, India, elucidating role of Wnt signaling and its downstream target genes in mediating osteoblast differentiation of human mesenchymal stem cells, and identified lithium as a priming agent for enhancing osteogenic differentiation potential of mesenchymal stem cells. In 2014, he joined CSIR-Indian Institute of Toxicology Research, Lucknow, India, as a Scientist. His group is working in varied disciples such as stem cell toxicology, embryonic stem cell differentiation, leukemia chemoresistance and wound healing. He has mentored a number of graduate/post-graduate students and is guiding Ph.D. scholars.
Affiliations and expertise
Senior Scientist, System Toxicology and Health Risk Assessment, CSIR-Indian Institute of Toxicology Research, Lucknow, IndiaPR
Pawan Kumar Raghav
Dr. Pawan Kumar Raghav is currently a researcher the School of Medicine, Department of Surgery, University of California, San Francisco. He is developing novel approaches for investigating immune/inflammatory mechanisms of allograft injury and discovering new biomarkers and therapeutics in solid organ and bone marrow transplantation. He is the recipient of several awards and honors, including the ICMR Travel Award to deliver an oral talk in 11th world congress & expo on cell & stem cell research in Orlando, FL; Research Excellence Award from the Institute of Scholars, best Research Award from Science Father, and was invitated to present the research proposal at BioMed X GmbH, Germany. He has published more than 40 publications, including international research articles, book chapters, books, and intellectual property rights for patents. He is also reviewer and editor of special collections for several international journals and books.
Affiliations and expertise
Researcher, University of California, San Francisco.NT
Nishant Tyagi
Nishant Tyagi MSc is an Indian-born Senior Research Fellow, presently working at Stem Cells and Gene Therapy Research Group, Institute of Nuclear Medicine and Allied Sciences under Defence Research & Development Organisation, India. He graduated from Kirorimal College, University of Delhi, India, and completed his master’s degree from Jamia Hamdard, New Delhi, India, in Biotechnology. He is a recipient of several awards and fellowships like NET-JRF, IIT GATE, and DRDO fellowship. He joined the Stem Cells and Gene Therapy Research Group in 2018 and has maintained a proactive approach to the research project and input ideas along with solid knowledge and research experience in biomaterial science. He is currently working under the guidance of Dr. Yogesh Kumar Verma, Senior Scientist, INMAS, in multiple defense-funded projects and has published several publications and filed many patents.
Affiliations and expertise
Senior Research Scholar, Stem Cell & Gene Therapy Research Group, Institute of Nuclear Medicine and Allied Sciences, Delhi, IndiaSK
Subodh Kumar
Subodh Kumar MSc is an Indian-born Senior Research Fellow, currently working in Stem Cells and Gene Therapy Research Group, Institute of Nuclear Medicine and Allied Sciences, DRDO, in the defence funded project. Over the past two and half years he has worked in many research projects in the AIIMS and INMAS. He has earned his B.Sc. degree from Hansraj College, Delhi University and M.Sc. degree (Medical Biotechnology) from Maharishi Dayanand University, Rohtak, Haryana, sponsored by Department of Biotechnology, Government of India (PG research fellow).
He has also qualified, GATE and CSIR JRF fellowship conducted by IITs and CSIR on behalf of Government of India respectively. He joined PhD under the supervision of senior scientist Dr. Yogesh Kumar (Sc. E), INMAS, DRDO.
Subodh Kumar has published many research papers and book chapters.
He is correctly putting his intellect for the research community through his writing and brain-storming scientific ideas.
Affiliations and expertise
Senior Research Scholar, Stem Cell and Gene Therapy Research Group, Institute of Nuclear Medicine and Allied Sciences, Delhi, IndiaRead Stem Cells on ScienceDirect